BR112018009851A2 - polipeptídios mutados de hev e uso dos mesmos para a contagem de anticorpos anti-hev - Google Patents
polipeptídios mutados de hev e uso dos mesmos para a contagem de anticorpos anti-hevInfo
- Publication number
- BR112018009851A2 BR112018009851A2 BR112018009851A BR112018009851A BR112018009851A2 BR 112018009851 A2 BR112018009851 A2 BR 112018009851A2 BR 112018009851 A BR112018009851 A BR 112018009851A BR 112018009851 A BR112018009851 A BR 112018009851A BR 112018009851 A2 BR112018009851 A2 BR 112018009851A2
- Authority
- BR
- Brazil
- Prior art keywords
- hev
- orf2 protein
- amino acid
- mutated
- positions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
- C07K14/10—Hepatitis A virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
a presente invenção refere-se a polipeptídio da proteína p-orf2 do vírus da hepatite e compreendendo pelo menos a sequência de aminoácidos 394-660, numerados em relação a uma proteína p-orf2 de 660 aminoácidos, na qual as três cisteínas nas posições 627, 630 e 638 foram mutadas ou, para uma proteína p-orf2 de comprimento diferente, pelo menos a sequência de aminoácidos correspondente aos aminoácidos 394-660 da proteína p-orf2 de 660 aminoácidos, na qual as três cisteínas situadas nas três posições correspondentes às posições 627, 630 e 638 da proteína p-orf2 de 660 aminoácidos foram mutadas. ela também se refere a processos de determinação da presença de resposta humoral ou da taxa de anticorpos direcionados contra a proteína p-orf2 utilizando esses polipeptídios, assim como seu uso no contexto de uma infecção pelo vírus da hepatite e. sem desenhos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1561596 | 2015-11-30 | ||
| FR1561596A FR3044312B1 (fr) | 2015-11-30 | 2015-11-30 | Polypeptides mutes de hev et leur utilisation pour le dosage d'anticorps anti-hev |
| PCT/FR2016/053127 WO2017093649A1 (fr) | 2015-11-30 | 2016-11-29 | Polypeptides mutés de hev et leur utilisation pour le dosage d'anticorps anti-hev |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018009851A2 true BR112018009851A2 (pt) | 2018-11-13 |
| BR112018009851B1 BR112018009851B1 (pt) | 2025-06-17 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| FR3044312B1 (fr) | 2017-12-08 |
| FR3044312A1 (fr) | 2017-06-02 |
| WO2017093649A1 (fr) | 2017-06-08 |
| ES2912907T3 (es) | 2022-05-30 |
| US10408841B2 (en) | 2019-09-10 |
| US20180328929A1 (en) | 2018-11-15 |
| CN108473540A (zh) | 2018-08-31 |
| EP3383887A1 (fr) | 2018-10-10 |
| KR20180083941A (ko) | 2018-07-23 |
| EP3383887B1 (fr) | 2022-03-16 |
| CN108473540B (zh) | 2022-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017009954A2 (es) | Dominios diseñados con repeticiones de anquirina con especificidad de unión para la seroalbúmina | |
| BR112018073761A2 (pt) | proteínas de ligação ao cd3 de fragmento variável de cadeia única | |
| BR112016028066A2 (pt) | composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira | |
| MD4655B1 (ro) | Virusurile bolii de Newcastle şi utilizarea acestora | |
| MY196882A (en) | Recombinant binding proteins and their use | |
| BR112016030965A2 (pt) | Composições de veículo-anticorpo e métodos de fabricação e uso das mesmas | |
| MA41313A (fr) | Anticorps de liaison de la protéine april modifiés | |
| MX2017008643A (es) | Proteina de fusion que comprende un dominio de union a ligando de factor de crecimiento endotelial vascular (vegf) y factor de crecimiento derivado de plaquetas (pdgf). | |
| EA201892325A1 (ru) | Композиции и способы детектирования белков клетки-хозяина | |
| BR112017009764A2 (pt) | anticorpos biespecíficos e métodos de uso em oftalmologia | |
| IL292625A (en) | Viruses with modified capsid proteins | |
| BR112017001463A2 (pt) | célula hospedeira melhorada para produzir proteínas | |
| MX383506B (es) | Parvovirus porcino. | |
| DK3146042T3 (da) | Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop | |
| BR112016024462A2 (pt) | ?métodos para a preparação de uma proteína, proteína heteromultimérica, composição e célula hospedeira? | |
| UY36262A (es) | Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso | |
| BR112015004629A2 (pt) | polipeptídeos de clostridium difficile como vacinas | |
| WO2014152946A3 (en) | Polypeptides for treating and/or limiting influenza infection | |
| MX373809B (es) | Virus de la viruela porcina recombinante y vacunas. | |
| EP3404039A4 (en) | RECOMBINANT PICP PROTEIN AND METHOD FOR PRODUCING SPECIALLY BINDING ANTIBODIES THEREOF | |
| WO2013138259A3 (en) | Polypeptides for treating and/or limiting influenza infection | |
| EA201890187A1 (ru) | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита | |
| MX2018002616A (es) | Proteina de fusion. | |
| BR112018009851A2 (pt) | polipeptídios mutados de hev e uso dos mesmos para a contagem de anticorpos anti-hev | |
| EA201992348A1 (ru) | АНТИГЕН-СВЯЗЫВАЮЩИЕ БЕЛКИ, ВЗАИМОДЕЙСТВУЮЩИЕ С Jagged1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/11/2016, OBSERVADAS AS CONDICOES LEGAIS |